Pancreatic disease
basic science and clinical management
Our rough guess is there are 122,500 words in this book.
At a pace averaging 250 words per minute, this book will take 8 hours and 10 minutes to read. With a half hour per day, this will take 17 days to read.
How long will it take you?
This book will take an estimated to read at a reading speed averaging words per minute. With 30 minutes per day, this will take to read.
Enter your reading speedYou can take one of our WPM reading speed tests to find your reading speed.
Create a free account to track your reading progress, build your reading list, and set reading goals.
We earn a commission on purchases
Contributions
- Johnson, C. D. 1952- - Contributor
- Imrie, C. W. - Contributor
Publication
2004 - Springer, London, England
Language
English
Word Count
122,500 words, Guess
Page Count
490 pages
Identifiers
- Open LibraryOL19290255M
- ISBN-101852337117
- OCLC Control Number52471422
- OCLC Control Numberpancreaticdiseas0000unse_s7n6
- Library of Congress Control Number2003054423
and 1 more
- Goodreads4361518
Classifications
- DDC616.3/7
- LCCRC857 .P295 2004
Description
Pancreatic Disease in the 21st Century summarises the state of the art in basic research and clinical management of pancreatic disease. This book provides a clear and up-to-date review of the advancing areas in clinical pancreatology and clinical research related to the pancreas. Written by leading experts in the field who are actively involved in research, this comprehensive review of current progress directs the interested reader towards important up-to-date published source material. Covering all aspects of pancreatic disease, contributions are included from pancreatic surgeons and medical pancreatologists on pancreatic cancer, acute pancreatitis and chronic pancreatitis. Special features include a systematic review of the evidence for the use of gemcitabine in pancreatic cancer prepared for the National Institute of Clinical Excellence (NICE), the UK body charged with evaluating new drug treatment. Gemcitabine has FDA approval. There are several contributions dealing with the management of pancreatic neuroendocrine tumours. This book will be useful to gastroenterologists, internists and surgeons, and specialist clinicians with an interest in pancreatic disease. Trainees in medical and surgical pancreatology will find it a useful supplement to standard textbooks, providing up-to-the-minute information.
Subjects
Topics
Other Editions
- Pancreatic disease: basic science and clinical management
Reader Reviews
No reviews yet for this book.
Be the first to share your thoughts!